NDATOPICALTAPE
Approved
Jul 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
5/8 — Partial
CORDRAN (flurandrenolide) by Almirall is corticosteroid hormone receptor agonists [moa]. Approved for corticosteroid [epc]. First approved in 1969.
Drug data last refreshed 2h ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CORDRAN (flurandrenolide) is a topical corticosteroid available as a medicated tape formulation that treats inflammatory and pruritic dermatological conditions. It works by stabilizing cellular and lysosomal membranes to reduce inflammation, itching, and vasodilation. The drug has been on the market since 1969 and remains a specialized option for patients requiring sustained topical corticosteroid delivery.
$3MPart D
LOE ApproachingModest market size with declining patent protection signals a mature, stable brand requiring defensive commercial strategies and small, lean team structures.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CORDRAN offers minimal career momentum given its approaching LOE, low Medicare spending ($3M), and zero linked job count. Roles on this product are primarily defensive, cost-focused, or transition-oriented, with limited advancement potential.
Brand ManagerField Sales Representative
Worked on CORDRAN at Almirall? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.